Magnesium Sulfate for Intraoperative Neuromonitoring

"There is a wealth of clinical data supporting Magnesium sulfate's safety, thus it was granted an impressive rating of 3."

"Patients must be older than 18 years yet younger than 80 to qualify for this medical trial."

"Correct. The online registry of clinicaltrials.gov affirms that this medical investigation is presently enrolling patients; it was initially posted on March 18th 2022 and most recently updated on July 7th 2022. It requires 50 participants to be sourced from 2 distinct sites."

"Affirmative. As evidenced on the clinicaltrials.gov website, this medical trial is still open for enrollment and began recruiting patients in March of 2022; the data was last updated on July 7th. Fifty participants will be accepted at two different sites."

"This medical study seeks 50 candidates aged 18-80 years who are undergoing elective spine or cranial surgery with the intention of using intraoperative neuromonitoring including SSEP and TcMEP."

"Presently, 27 clinical trials that involve the use of Magnesium sulfate are active with 8 in their final stage. While most sites for this research are in Guangzhou, Guangdong Province, there are 42 overall locations running trials on Magnesium sulphate."

"Magnesium sulfate is a common remedy for hypomagnesemia, but also has applications in cases of poisoning, prophylactic low magnesium levels, and contusions."